Breaking Alzheimer's: A 15 Year Crusade to Expose the Cause and Deliver the Cure - Dayan Goodenowe

Descriere

nBreaking Alzheimer's is Dr. Dayan Goodenowe's story of personal and scientific perseverance. The biochemical mechanisms of neurological disease is his area of expertise and was his area of expertise for 15 years before he serendipitously discovered that low plasmalogen levels were causing Alzheimer's. Dr. Goodenowe had never heard of plasmalogens and he had never been taught about them. There are now 15 years of supportive validation of this discovery and access to plasmalogen testing and supplementation is now available to everyone. By sheer will, Dr. Goodenowe has completed the beginning and the middle of this journey such that the plasmalogen genie cannot be put back in the bottle. This book is about bringing the reader up to speed as to where we currently are on this journey and where we are going from here. n nThe Breaking Alzheimer's Video Series and Audio Book will be available through Dr. Dayan Goodenowe's website soon. Learn more about Dr. Goodenowe and his educational content here: https: //drgoodenowe.com n nTo learn more about Dr. Goodenowe's scientifically designed supplements and blood testing technology visit the Prodrome Sciences website here: https: //prodrome.com n nADVANCE PRAISE nA paradigm-altering view of Alzheimer's. nDale Bredesen, MD nAuthor of The New York Times Bestseller The End of Alzheimer's n nA brilliant and ground-breaking text on the science and clinical application of plasmalogens for the therapeutic amelioration of Alzheimer's Dementia. I have had the good fortune of observing firsthand the significant, clinical benefits in my patients with neurodegenerative disorders for whom I've prescribed plasmalogen therapy.Mitchel Fleisher M.D., D.Ht., D.A.B.F.M., Dc.A.B.C.T. nMedical Director, Center for Integrative & Regenerative Medicine n nA bold and promising approach. Dr. Goodenowe has performed groundbreaking and compelling research which is detailed in the book so that afflicted patients and health professionals will become aware of a discovery which may very well change our approach to Alzheimer's. We have been deploying plasmalogen precursors at the Regenesis Project and have found that within the timeframe of a few weeks, people become more alert and cognizant. nSheldon Jordan, MD, FAAN, DABPN, DABCN nMedical Director, the Regenesis Project n nDr. Goodenowe has not only identified a biomarker-plasmalogen-that is strongly correlated with dementia, but he has also discovered a